|
The Role of Combined MRI & MRSI in Treating Prostate Cancer
Clinical assessment of the extent of prostate cancer (PC) is often difficult because
of the relatively small size and complex anatomy of the prostate and its
inaccessible location deep within the pelvis. Traditionally, the extent of PC has
been evaluated by digital rectal examination (DRE) in combination with other
clinical data (PSA, number of positive biopsies or core percentage positive for
PC). Increased awareness of limitations of traditional methods for diagnosis and
staging of PC has mobilized the development and application of new imaging
modalities for its assessment. Several new non-invasive imaging techniques, such
as transrectal ultrasound of the prostate (TRUSP) have been developed to aid in
this evaluation. However, these diagnostic modalities still have limitations. Even
when combined with other clinical tools they often cannot consistently provide all
the information needed by physicians.
The Role of Combined MRI Entire Article (PDF)
|
